Compounds > pyrimidin-2-one beta-ribofuranoside
Page last updated: 2024-08-26

pyrimidin-2-one beta-ribofuranoside and Colorectal Neoplasms

pyrimidin-2-one beta-ribofuranoside has been researched along with Colorectal Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, CC; Lin, YT; Luo, CK; Shun, CT; Tang, SP; Tsai, CT; Wei, TT1
Hosokawa, M; Iwakawa, S; Kobori, A; Matsubara, E; Matsumura, J; Tanaka, S; Ueda, K1
Chen, CC; Chuang, SH; Lin, SH; Lin, YT; Shun, CT; Wei, TT; Wu, MS; Yang, PM1
Flis, K; Flis, S; Gnyszka, A1
Chuang, JC; Jones, PA; Kwan, JM; Li, TW; Liang, G; Yang, AS; Yoo, CB1

Other Studies

5 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Colorectal Neoplasms

ArticleYear
Metabolic targeting of HIF-1α potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer.
    Oncogene, 2020, Volume: 39, Issue:2

    Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Cytidine; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Hydroxylation; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Molecular Targeted Therapy; Neovascularization, Pathologic; Oxaliplatin; Protein Stability; Proteolysis; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2020
Effects of Zebularine on Invasion Activity and Intracellular Expression Level of let-7b in Colorectal Cancer Cells.
    Biological & pharmaceutical bulletin, 2017, Aug-01, Volume: 40, Issue:8

    Topics: Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cytidine; DNA Methylation; DNA Modification Methylases; Drug Resistance, Neoplasm; Enzyme Inhibitors; Exosomes; Humans; MicroRNAs; Neoplasm Invasiveness; Organoplatinum Compounds; Oxaliplatin; Transfection; Up-Regulation

2017
Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress.
    Scientific reports, 2013, Nov-14, Volume: 3

    Topics: Animals; Autophagy; Carcinogenesis; Cell Death; Cell Line; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; DNA Damage; DNA Methylation; Down-Regulation; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; HCT116 Cells; HeLa Cells; Humans; Male; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Proto-Oncogene Proteins c-mdm2; Ribosomal Proteins; Signal Transduction; Tumor Suppressor Protein p53; Unfolded Protein Response; Up-Regulation

2013
DNA methyltransferase inhibitors improve the effect of chemotherapeutic agents in SW48 and HT-29 colorectal cancer cells.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; DNA Damage; DNA-Cytosine Methylases; Enzyme Inhibitors; Fluorouracil; Humans; Membrane Potential, Mitochondrial; Organoplatinum Compounds; Oxaliplatin

2014
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
    Molecular cancer therapeutics, 2005, Volume: 4, Issue:10

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; Deoxycytidine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; HT29 Cells; Humans; Hydralazine; Male; Procainamide; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction

2005